Io Biotech, Inc. lost $1.45 per diluted share in fiscal year 2024. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a loss of $1.35 per diluted share. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters Io Biotech, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Io Biotech, Inc.'s diluted earnings per share in fiscal year 2024?
Io Biotech, Inc. lost $1.45 per diluted share in fiscal year 2024.
What is Io Biotech, Inc.'s diluted earnings per share over the last twelve months?
Io Biotech, Inc. (IOBTQ) reported a loss of $1.35 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
What was Io Biotech, Inc.'s diluted earnings per share in the most recent quarter?
Io Biotech, Inc. (IOBTQ) reported -$0.13 in diluted earnings per share in Q3 2025. This represents an increase of 63.9% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Io Biotech, Inc. (IOBTQ) reported on that line in every period on record.
